Related references
Note: Only part of the references are listed.Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease
Ajeet Rijal Upadhaya et al.
BRAIN (2014)
Oligomers, fact or artefact? SDS-PAGE induces dimerization of β-amyloid in human brain samples
Andrew D. Watt et al.
ACTA NEUROPATHOLOGICA (2013)
Pyroglutamate-3 Amyloid-β Deposition in the Brains of Humans, Non-Human Primates, Canines, and Alzheimer Disease-Like Transgenic Mouse Models
Jeffrey L. Frost et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach
Thomas J. Montine et al.
ACTA NEUROPATHOLOGICA (2012)
Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β
Justin M. Nussbaum et al.
NATURE (2012)
Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice
Ajeet Rijal Upadhaya et al.
NEUROBIOLOGY OF AGING (2012)
Selective Hippocampal Neurodegeneration in Transgenic Mice Expressing Small Amounts of Truncated Aβ Is Induced by Pyroglutamate-Aβ Formation
Anca Alexandru et al.
JOURNAL OF NEUROSCIENCE (2011)
Amyloid-β/Fyn-Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease
Erik D. Roberson et al.
JOURNAL OF NEUROSCIENCE (2011)
Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
Ming Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The presence of sodium dodecyl sulphate-stable Aβ dimers is strongly associated with Alzheimer-type dementia
Jessica M. Mc Donald et al.
BRAIN (2010)
Pyroglutamate-Aβ: Role in the natural history of Alzheimer's disease
Adam P. Gunn et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport
Keith A. Vossel et al.
SCIENCE (2010)
Classification and basic pathology of Alzheimer disease
Charles Duyckaerts et al.
ACTA NEUROPATHOLOGICA (2009)
Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model
Oliver Wirths et al.
ACTA NEUROPATHOLOGICA (2009)
Pyroglutamate Formation Influences Solubility and Amyloidogenicity of Amyloid Peptides
Dagmar Schlenzig et al.
BIOCHEMISTRY (2009)
N-Terminal Truncated Pyroglutamyl β Amyloid Peptide Aβpy3-42 Shows a Faster Aggregation Kinetics than the Full-Length Aβ1-42
Cristina D'Arrigo et al.
BIOPOLYMERS (2009)
Immunodominant epitope and properties of pyroglutamate-modified Aβ-specific antibodies produced in rabbits
G. Acero et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Amyloidogenic processing of amyloid precursor protein:: Evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-β
Holger Cynis et al.
BIOCHEMISTRY (2008)
Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology
Stephan Schilling et al.
NATURE MEDICINE (2008)
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model
Erik D. Roberson et al.
SCIENCE (2007)
On the seeding and oligomerization of pGlu-amyloid peptides (in vitro)
Stephan Schilling et al.
BIOCHEMISTRY (2006)
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2006)
β-amyloid is different in normal aging and in Alzheimer disease
A Piccini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions
S Schilling et al.
FEBS LETTERS (2004)
Pyroglutamate-modified amyloid β-peptides -: AβN3(pE)-strongly affect cultured neuron and astrocyte survival
C Russo et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
DR Thal et al.
NEUROLOGY (2002)
Amyloid β protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain
Y Harigaya et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
